Get the Daily Brief
Latest Biotech News
Breakthroughs in Diabetes and Obesity Drug Development Highlight Industry Momentum
Lilly overtook Novo Nordisk in sales of GLP-1 receptor agonists across diabetes and obesity markets by Q2 2025, signaling intensified competition in this expanding therapeutic area. The company...
Innovative Technologies and Platforms Accelerate Biomanufacturing and Diagnostics
Researchers at North Carolina State University achieved dramatic pDNA yield enhancements by controlling E. coli evolution, a step that promises to lower gene therapy manufacturing costs....
Groundbreaking Neuroscience Insights from Organoids and Stem Cell Research
Neural organoids are revolutionizing neuroscience research by enabling complex studies of human brain development, disease modeling, and therapeutic discovery previously inaccessible through...
New Frontiers in Cancer Immunotherapy and Resistance Mechanisms
Recent studies reveal novel therapeutic targets and resistance pathways in cancer treatment. Research identified EPIC1 long noncoding RNA as a driver of immunotherapy resistance in triple-negative...
Bayer and Kumquat Strike $1.3 Billion KRAS G12D Cancer Deal
Bayer AG has entered a global exclusive license and collaboration with Kumquat Biosciences to develop and commercialize Kumquat's KRAS G12D inhibitor, targeting one of the most prevalent oncogenic...
Insmed’s Brinsupri Approved as First Drug for Non-CF Bronchiectasis
The FDA has approved Insmed’s Brinsupri (brensocatib), the first therapy specifically indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB), a chronic respiratory disease...
AI-Driven Advances Transform Gene Editing and Drug Design
Researchers have integrated artificial intelligence into genetic engineering to significantly enhance precision and efficiency. The University of Zurich team developed Pythia, an AI model...
Broad-Spectrum mRNA Antiviral Emerges from Rare Immune Disorder Study
Inspired by insights into ISG15 deficiency, researchers at Columbia University engineered an mRNA-based antiviral showing broad activity against diverse viruses including Zika, SARS-CoV-2, and...
Novel Lithium Battery and Energy Storage Technologies Advance
Recent studies have introduced innovative materials and methods enhancing lithium and zinc battery performance. Researchers from Helmholtz-Zentrum Berlin used neutron tomography to clarify...
Cancer Immunotherapy and Target Discovery Make New Headway
Multiple pioneering cancer research studies have unveiled promising therapeutic targets and treatment strategies. The University of Pittsburgh identified lncRNA EPIC1 as a driver of immune evasion...
mRNA Vaccine Funding Faces Federal Withdrawal Amid Trust Concerns
The Biomedical Advanced Research and Development Authority (BARDA) terminated 22 grants supporting mRNA vaccine development, resulting in withdrawal of nearly $500 million in federal funding. This...
Breakthroughs in Neuroscience with Human Brain Organoids
Neural organoids are advancing research in human brain development and disease modeling, providing unprecedented biological insight. Researchers at University of California San Diego and the...
Cancer Drug Approvals and Clinical Trial Advances
Recent clinical trial results and drug approvals are shaping cancer treatment landscapes. Pfizer and Merck's combination therapy of Padcev and Keytruda demonstrated survival improvements in...
AI Reshapes Biopharma Drug Discovery and Clinical Trial Monitoring
Artificial intelligence continues to transform biopharma development and clinical trial operations. 10x Genomics’ acquisition of Scale Biosciences enhances single-cell sequencing capacity and...
Bayer-Kumquat KRAS G12D Oncology Deal Reaches $1.3 Billion Potential
Bayer AG has entered a substantial global licensing and collaboration agreement with Kumquat Biosciences to develop and commercialize a KRAS G12D inhibitor, a promising targeted therapy for...
FDA Approves Insmed’s Brinsupri for Non-Cystic Fibrosis Bronchiectasis
Insmed has achieved a regulatory milestone with the FDA approval of Brinsupri (brensocatib), the first and only treatment specifically approved for non-cystic fibrosis bronchiectasis (NCFB)....
AI Designs DNA Repair Templates Enhancing CRISPR Precision
Researchers at the University of Zurich have developed an artificial intelligence-based tool named Pythia to predict DNA repair outcomes following CRISPR/Cas9 editing. This deep learning-assisted...
Advances in Cancer Immunotherapy: Targeting Resistant Tumors and Novel Vaccines
Recent breakthroughs in immunotherapy focus on overcoming therapeutic resistance and improving treatment efficacy across cancer types. Studies reveal that the long noncoding RNA EPIC1 suppresses...
Generative AI Advances Small Enzyme Design for Bioprocessing
Scientists from Kyushu University have leveraged ProtGPT2, a protein language model, to generate novel small enzyme variants optimized for bioprocessing applications. This in silico approach...
Expansion of AbbVie's U.S. Manufacturing with $195 Million Facility
AbbVie announced a $195 million investment to build a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago. This expansion supports domestic production for...